Month: August 2025
Volta Finance Limited (VTA / VTAS)July 2025 monthly report
NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES
Guernsey, August 21st, 2025
AXA IM has published the Volta Finance Limited (the “Company” or “Volta Finance” or “Volta”) monthly report for July 2025. The full report is attached to this release and will be available on Volta’s website shortly (www.voltafinance.com).
Performance and Portfolio Activity
Dear Investors,
In July, Volta Finance achieved a net performance of +2.48% (including a dividend payment of 15.5 cents per share), bringing the Financial Year net performance to +13.9% (August 2024 to July 2025). To frame this performance in perspective with the broader Credit markets, US High Yield returned +8.6% between August 2024 and July 2025, while Euro High Yield returned +8.1% in...
Duluth Holdings Inc. to Report Second Quarter 2025 Financial Results on September 4, 2025
Written by Customer Service on . Posted in Public Companies.
MOUNT HOREB, Wis., Aug. 21, 2025 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s casual wear, workwear and accessories, today announced that it will report second quarter 2025 financial results before market on Thursday, September 4, 2025.
A conference call and audio webcast with analysts and investors will be held on Thursday, September 4, 2025, at 9:30am Eastern Time to discuss the results and answer questions.
Live conference call: 1-844-875-6915 (domestic) or 1-412-317-6711 (international)Conference call replay available through September 10, 2025: 1-877-344-7529 (domestic) or 1-412-317-0088 (international)Replay access code: 1218574
Live and archived webcast: ir.duluthtrading.com
To expedite entry into the call and avoid waiting...
Precore Gold Announces up to C$2 Million Private Placement
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Aug. 21, 2025 (GLOBE NEWSWIRE) — Precore Gold Corp. (CSE: PRCG) (the “Company” or “Precore Gold”) is pleased to announce that it has arranged, subject to receipt of regulatory approval, a non-brokered private placement (the “Private Placement”) to raise gross proceeds of up to $2,000,000. The Private Placement will consist of the sale of up to 11,111,111 units of the Company (the “Units”) at a price of $0.18 per Unit, with each Unit consisting of one common share of the Company (a “Common Share”) and one-half of one share purchase warrant (each whole share purchase warrant, a “Warrant”). Each Warrant will entitle the holder to purchase one additional Common Share (a “Warrant Share”) for a period of thirty-six (36) months at an exercise price of $0.25 per Warrant Share. The Company may pay a finder’s...
WeRide Unveils WePilot AiDrive, A One-Stage End-to-End ADAS Targeted for Mass Production in 2025
Written by Customer Service on . Posted in Public Companies.
GUANGZHOU, China, Aug. 21, 2025 (GLOBE NEWSWIRE) — WeRide (Nasdaq: WRD), a global leader in autonomous driving technology, today launched WePilot AiDrive, its one-stage end-to-end ADAS (Advanced Driver Assistance System) solution. Developed in partnership with leading Tier 1 supplier Bosch, this milestone comes just six months after both companies brought their two-stage end-to-end solution into mass production.
Unlike the traditional two-stage process of sensing and then decision-making, WePilot AiDrive integrates both into a one-stage architecture, enabling vehicles to “see and act” at the same time — like a skilled human driver. This delivers faster responses, shorter driving routes, and greater fault tolerance.
WePilot AiDrive has completed core function validation and is expected to enter mass production and vehicle...
Kaldalón hf.: Bill Auction Announcement
Written by Customer Service on . Posted in Public Companies.
On Monday, 25 August, Kaldalón hf. will auction six-month bills in a new series, KALD 26 0302 bills. The auction is held in line with the company’s policy to be a regular issuer of bills and bonds.
The auction will be conducted using the Dutch method, i.e. all accepted bids will be sold to investors at the highest accepted flat yield. The bills will be issued in nominal value units of ISK 20 million. The company reserves the right to accept all bids, reject all bids, or accept bids in part. The results of the auction and allocation to investors will be announced no later than prior to market opening on Tuesday, 26 August.
Landsbankinn hf. will manage the auction. Bids, stating nominal amount and flat yield, must be submitted to Landsbankinn hf. no later than 16:00 on Monday, 25 August, at the email address: verdbrefamidlun@landsbankinn.is.Payment...
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
Written by Customer Service on . Posted in Public Companies.
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD)Approval is based on comprehensive analytical, non-clinical and clinical similarity data, including a confirmatory efficacy study comparing Mynzepli® with the reference biologic Eylea® in patients with neovascular AMDREYKJAVIK, ICELAND and LONDON, UK (August 21, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Commission...
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
Written by Customer Service on . Posted in Public Companies.
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD)Approval is based on comprehensive analytical, non-clinical and clinical similarity data, including a confirmatory efficacy study comparing Mynzepli® with the reference biologic Eylea® in patients with neovascular AMDREYKJAVIK, Iceland and LONDON, Aug. 21, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European...
Columbus Interim Report Q2 2025
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Company announcement no. 17/2025
Market caution reflected in Q2 resultsColumbus experienced increased macro-economic headwinds in Q2 2025, leading to prolonged sales cycles and postponed IT project decisions. As a result, revenue decreased by 4% and EBITDA amounted to DKK 16m in Q2 2025, corresponding to an EBITDA margin of 4%, compared to 7% in Q2 2024. Despite the decline in revenue, we maintain a stable operational business with positive cashflow from operating activities, up 15% compared with Q2 2024. The outlook for 2025 has been adjusted to reflect current market conditions.
“While the current market conditions require us to adjust our short-term expectations, we remain confident in Columbus’ long-term growth potential and continue to execute our New Heights strategy with discipline and focus,” says CEO & President, Søren Krogh...
cBrain® advances global growth strategy, maintaining long-term focus
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Company Announcement no. 08/2025
cBrain® advances global growth strategy, maintaining long-term focus
Copenhagen, August 21, 2025
We are now entering the final half year of our 2023–2025 growth plan. We see standard software for government evolving into a large industry, challenging the dominance of traditional suppliers. With more than 15 years of experience, a strong product position, and solid customer references, we look confidently toward the next decade.
We aim to take a leadership position within the commercial off-the-shelf (COTS) software for government industry, and we have refined our strategy accordingly. Our dual go-to-market approach balances depth with focus: we continue to build our core business around large account customers (“super accounts”), while in parallel pursuing global leadership in selected niches where...
Vow ASA: Invitation to presentation of second quarter and first half year 2025
Written by Customer Service on . Posted in Public Companies.
Vow ASA (OSE: VOW) will release its report for the second quarter and first half year 2025 on Thursday 28 August 2025. The update will be published on https://newsweb.oslobors.no/ and on the company’s web site www.vowasa.com.
Vow ASA is pleased to invite shareholders, investors, analysts, and other interested parties to a presentation of the results and a Q&A at 09:00 CET on the same day. Personal attendance is welcomed at Haakon VII’s gate 2, 0161 Oslo.
The session will also be streamed via webcast. To register and follow the presentation online, please copy and paste the following link into your browser, click Attend and register your e-mail: https://channel.royalcast.com/landingpage/hegnarmedia/20250828_3/
For further information, please contact:
Gunnar Pedersen, CEO, Vow ASA
Tel: +47 91 63 03 04
Email: gunnar.pedersen@vowasa.com
Cecilie...
